Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-31 Sale | 2024-02-02 5:25 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,499 | $32.35 | $1,860,019 | 4,066,774 (Direct) | View |
| 2024-01-02 Sale | 2024-01-04 5:25 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 9,952 | $31.01 | $308,637 | 3,715,048 (Direct) | View |
| 2023-12-20 Sale | 2023-12-22 5:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 12,000 | $28.54 | $342,480 | 3,725,000 (Direct) | View |
| 2023-10-25 Sale | 2023-10-27 6:23 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 24,338 | $24.21 | $589,223 | 3,737,000 (Direct) | View |
| 2023-09-18 Sale | 2023-09-20 6:10 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,755 | $28.12 | $1,624,223 | 4,170,563 (Direct) | View |
| 2023-05-03 Sale | 2023-05-05 7:04 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 104,928 | $39.32 | $4,125,674 | 4,745,298 (Direct) | View |
| 2022-02-11 Sale | 2022-02-14 08:54 am | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 146,388 | $51.91 | $7,598,864 | 4,672,667 (Direct) | View |
| 2021-12-15 Sale | 2021-12-17 8:14 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 60,000 | $67.56 | $4,053,431 | 3,219,022 (Direct) | View |
| 2021-10-20 Sale | 2021-10-22 5:58 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 65,000 | $65.77 | $4,274,982 | 3,279,022 (Direct) | View |
| 2020-12-08 Sale | 2020-12-10 7:07 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 55,000 | $68.73 | $3,780,347 | 4,224,999 (Direct) | View |
| 2020-10-23 Sale | 2020-10-23 7:35 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 100,000 | $58.21 | $5,821,032 | 2,505,237 (Direct) | View |
| 2020-08-13 Sale | 2020-08-14 6:08 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 50,000 | $41.35 | $2,067,500 | 3,500,780 (Direct) | View |
| 2020-06-25 Sale | 2020-06-26 6:02 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 100,000 | $38.81 | $3,881,017 | 2,605,237 (Direct) | View |
| 2019-12-24 Sale | 2019-12-27 4:54 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 83,333 | $63.5 | $5,291,646 | 1,805,237 (Direct) | View |
| 2019-12-12 Sale | 2019-12-13 6:35 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 183,333 | $67.15 | $12,310,119 | 1,888,570 (Direct) | View |
| 2019-12-02 Sale | 2019-12-04 6:48 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 50,000 | $67.33 | $3,366,522 | 2,071,903 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-31 Exercise | 2024-02-02 5:25 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,499 | $14.54 | 4,066,774 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 5:25 pm | 2015-02-06 2024-02-06 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,499 | $0 | 4,066,774 (Direct) | View |
| 2023-09-18 Exercise | 2023-09-20 6:10 pm | 2013-10-01 2023-09-21 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,555 | $0 | 4,170,563 (Direct) | View |
| 2023-09-18 Exercise | 2023-09-20 6:10 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 57,755 | $4.75 | 4,170,563 (Direct) | View |
| 2023-05-03 Exercise | 2023-05-05 7:04 pm | 2013-06-01 2023-05-06 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 104,928 | $0 | 4,745,298 (Direct) | View |
| 2023-05-03 Exercise | 2023-05-05 7:04 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 104,928 | $2.01 | 4,745,298 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 7:09 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 252,400 | $0 | 3,720,714 (Direct) | View |
| 2022-09-27 Exercise | 2022-09-29 5:15 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 39,082 | $30.77 | 3,468,314 (Direct) | View |
| 2022-09-27 Exercise | 2022-09-29 5:15 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 1,542 | $31.21 | 3,468,314 (Direct) | View |
| 2022-07-08 Disposition | 2022-07-12 7:39 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 551,197 | $0 | 3,508,938 (Direct) | View |
| 2022-07-07 Exercise | 2022-07-11 8:08 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 2,501 | $14.54 | 4,672,667 (Direct) | View |
| 2022-07-07 Exercise | 2022-07-11 8:08 pm | 2014-03-01 2024-02-06 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 2,501 | $0 | 4,672,667 (Direct) | View |
| 2022-02-11 Exercise | 2022-02-14 08:54 am | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 146,388 | $5.19 | 4,672,667 (Direct) | View |
| 2022-02-11 Exercise | 2022-02-14 08:54 am | 2012-03-01 2022-02-16 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 146,388 | $0 | 4,672,667 (Direct) | View |
| 2022-01-07 Exercise | 2022-01-07 9:39 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 11,806 | $5.19 | 4,819,055 (Direct) | View |
| 2022-01-07 Exercise | 2022-01-07 9:39 pm | 2012-03-01 2022-02-16 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 11,806 | $0 | 4,819,055 (Direct) | View |
| 2022-01-01 Option Award | 2022-01-04 9:22 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 800,000 | $0 | 4,045,828 (Direct) | View |
| 2021-12-23 Exercise | 2021-12-23 9:52 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 11,806 | $5.19 | 4,019,055 (Direct) | View |
| 2021-12-23 Exercise | 2021-12-23 9:52 pm | 2012-03-01 2022-02-16 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 11,806 | $0 | 4,019,055 (Direct) | View |
| 2021-01-01 Option Award | 2021-01-04 6:02 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 800,000 | $0 | 3,344,022 (Direct) | View |
| 2020-12-30 Gift | 2021-01-04 6:02 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 599 | $0 | 3,344,022 (Direct) | View |
| 2020-12-28 Gift | 2020-12-30 5:52 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 1,126 | $0 | 2,544,621 (Direct) | View |
| 2020-12-18 Exercise | 2020-12-22 5:55 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 28,274 | $6.15 | 4,174,087 (Direct) | View |
| 2020-12-18 Exercise | 2020-12-22 5:55 pm | 2013-10-01 2023-09-21 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 40,510 | $0 | 4,174,087 (Direct) | View |
| 2020-12-18 Exercise | 2020-12-22 5:55 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 12,236 | $4.75 | 4,174,087 (Direct) | View |
| 2020-12-08 Exercise | 2020-12-10 7:07 pm | 2013-06-01 2023-05-06 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 55,000 | $0 | 4,224,999 (Direct) | View |
| 2020-12-08 Exercise | 2020-12-10 7:07 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 55,000 | $2.01 | 4,224,999 (Direct) | View |
| 2020-08-13 Exercise | 2020-08-14 6:08 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 50,000 | $9.9 | 3,500,780 (Direct) | View |
| 2020-08-13 Exercise | 2020-08-14 6:08 pm | 2010-09-01 2020-08-16 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 50,000 | $0 | 3,500,780 (Direct) | View |
| 2020-01-01 Option Award | 2020-01-03 6:01 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer | 900,000 | $0 | 2,705,237 (Direct) | View |